Suggestions
Sebastian Seiguer, JD, MBA
CEO @ Scene Health | Medication Adherence
Sebastian Seiguer, JD, MBA, is the Chief Executive Officer and Co-Founder of Scene Health, a company dedicated to improving medication adherence through innovative digital health solutions. Formerly known as emocha Mobile Health, Scene Health utilizes a comprehensive 360° model of care that combines personalized video coaching and education to enhance patient engagement and adherence to medication regimens.12
Education and Background
Sebastian earned his Juris Doctor (JD) from Columbia Law School (1995-1998) and holds two Master of Business Administration (MBA) degrees from Johns Hopkins University, specializing in Health Care Administration and Management as well as Health Care and Finance (2011-2013). He also has a Bachelor of Arts in English from Columbia College (1991-1995) and studied English literature at Cambridge University.13
Career Highlights
- Scene Health: Since August 2013, Sebastian has led Scene Health in addressing the critical issue of medication nonadherence, which affects millions globally. The company employs video technology to facilitate Directly Observed Therapy (DOT), allowing healthcare professionals to monitor patients' medication intake remotely.12
- emocha Mobile Health: Prior to rebranding as Scene Health, he served as CEO of emocha Health, where he developed strategies to leverage technology for better health outcomes.15
- Johns Hopkins Technology Ventures: Before his role at Scene Health, Sebastian worked as a Technology Transfer Analyst, focusing on compliance and financial analysis related to licensing agreements.13
- San Francisco Coffee Company GmbH: He co-founded this company in Munich, Germany, where he served as CEO for over a decade before transitioning into healthcare.3
Recognition
Sebastian has been recognized for his contributions to digital health, including being named a Top 50 Digital Health Honoree by Rock Health in 2024. This recognition highlights his commitment to community-focused healthcare solutions and the successful application of evidence-based practices in public health settings.45
Vision and Impact
Sebastian Seiguer is passionate about using technology to bridge gaps in healthcare delivery. Under his leadership, Scene Health has developed solutions that not only improve medication adherence but also address broader social determinants of health that impact patient well-being. The company's innovative approach aims to make healthcare more accessible and effective for diverse populations across the United States and globally.124
Highlights
Sharing the 18th publication validating Scene Health (formerly emocha), this time in a study of > 700 patients with #hcv and #substanceusedisorders in the The Lancet. 91% of people in #directlyobservedtherapy achieved SVR (cure). Results were similar to a patient navigation model.
Patients who inject drugs (50% of whom had unstable housing) CAN ACHIEVE #hcv #cure given a little help with taking life-savings medications.
Thank you to the community health centers and opioid treatment programs in 8 cities who ran the study and do such great work: Johns Hopkins Medicine UCSF Department of Medicine Harvard Medical School Montefiore Clemson Medical Education Development Brown Medicine University of Washington Medical Center The University of New Mexico School of Medicine.
We are really lucky to get to work with world-class scientists: Alain Litwin, Judith Tsui, Seun Falade-Nwulia, Shruti Mehta, Arthur Kim, Julia Arnsten, Kimberly Page, and many others for including our DOT solution 5 years ago as we were just getting started.
Thanks to the excellent team Scene Health for putting heart and soul into helping people with serious challenges get better: Lauren Brown Morad Elmi, Amanda Allen and ex-Scenesters/emochans Katrina Rios, Valerie Garrison, Michelle Mendes.
The study was funded by Patient-Centered Outcomes Research Institute (PCORI) and Gilead Sciences provided the life-saving medications. Thanks to both institutions for funding ground-breaking work that will open up access to HCV treatment to the most vulnerable.
The National Institute on Drug Abuse (NIDA) Claritas Capital Kapor Capital PTX Capital TCP Venture Capital Healthworx Doba Parushev Thomas Carroll Wendy Faust Seraphine Kapsandoy, PhD, RN Jacki Porter Dayne Maust Karen S. Amstutz, MD MBA HLTH UCSF Health Hub Digital Health Awards Subbu Ramalingam UCSF Health Hub
